| Vol. 11.04 – 3 February, 2022 |
| |
|
|
| Scientists identified two 4q12 long noncoding RNAs, LCETRL3 and LCETRL4, which could significantly dimmish epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) efficiency. [Signal Transduction and Targeted Therapy] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Individual cystic fibrosis transmembrane conductance regulator gene function was defined by forskolin-induced swelling, measured as the relative size increase of intestinal organoids after stimulation with 0.8 µM forskolin, quantified as area under the curve. [European Respiratory Journal] |
|
|
|
| The authors found a highly significant correlation between pregnancy-associated plasma protein (PAPP)-A expression in idiopathic pulmonary fibrosis lung tissue and disease severity as measured by various pulmonary and physical function tests. [Journal of Cellular Physiology] |
|
|
|
| Researchers examined the effects of in vitro treatment of A549 human lung epithelial cells with 17-β-estradiol on mRNA expression of genes coding for these proteins. [Drug Development Research] |
|
|
|
| Utilizing an integrated strategy based on scRNA-seq, scTCR-seq, and bulk RNA-seq analysis of fibrotic hypersensitivity pneumonitis profiles, investigators identified ten major cell types and 19 unique subtypes. [Cell Death Discovery] |
|
|
|
| The authors examined the viability of BEAS-2B and mRNA/protein expression profile of oxidative stress and inflammatory response-related transcription factors and according inflammatory indicators with a view to evaluate the effects of different interaction models of PM2.5 on epithelial cell damage in vitro. [Environmental Science and Pollution Research] |
| |
|
|
| By utilizing a ΔNp63-specific conditional knockout mouse model and xenograft models of lung adenocarcinoma and squamous cell carcinoma, scientists found that ∆Np63 promoted NSCLC by maintaining the lung stem cells necessary for lung cancer cell initiation and progression in quiescence. [Nature Communications] |
|
|
|
| Researchers explored the biological function of circSHKBP1 in NSCLC. CircSHKBP1 was found to be upregulated in NSCLC tissues and cell lines and was enriched in exosomes derived from NSCLC cells. [Molecular Therapy Oncolytics] |
|
|
|
| The authors found that the expression of REV1 was significantly upregulated in lung cancer tissues compared with matched adjacent tissues and was associated with poor prognosis. [Cell Death & Disease] |
|
|
|
| The biological role of copine 1 (CPNE1) and receptor for activated C kinase 1 (RACK1) in NSCLC was investigated using gene expression knockdown and overexpression, cell proliferation assays, clonogenic assays, and Transwell assays. [Cell Communication and Signaling] |
|
|
|
| Investigators developed a lung adenocarcinoma (LUAD) hypoxia-related gene expression signature. RNAseq was used to identify genes significantly differentially expressed under hypoxia in four LUAD cell lines. [Scientific Reports] |
|
|
|
| The high expression of NEK2/3mRNA was significantly associated with poor prognosis in patients with NSCLC, while high expression of NEK1/4/6/7/8/9/10/11mRNA was associated with good prognosis. [Scientific Reports] |
|
|
|
| GEPIA database was employed to reveal the expression level of Ovarian tumor protease domain-containing protein 1 (OTUD1) in addition to Krüppel- like factor 4 (KLF4) in NSCLC tissue samples and prove the correlation between OTUD1 and KLF4. [Thoracic Cancer] |
|
|
|
|
| The authors discuss the underlying pathogenesis of irreversible pulmonary fibrosis as well as preclinical disease models, and also suggest directions for future studies. [Aging and Disease] |
|
|
|
| Scientists discuss the medical value of nutraceuticals briefly and their ability to mitigate various inflammatory lung diseases through targeting inhibition of NF-κB. [Chemico-Biological interactions] |
|
|
|
|
| A group of international respiratory societies has banned researchers associated with tobacco companies from publishing papers in their journals after the controversial acquisition of a health-care firm that makes inhalers by a tobacco giant. [Nature] |
|
|
|
| The Lung Cancer Research Foundation (LCRF) and KRAS Kickers announced a partnership aimed at raising much needed funds for research. Together they to pledged to fund at least one two-year grant in 2022 with the goal of improving outcomes for people with KRAS-mutant lung cancer. [Lung Cancer Research Foundation] |
|
|
|
|
| March 9 – 11, 2022 Melbourne, Victoria, Australia |
|
|
|
|
|
| King’s College London- London, England, United Kingdom |
|
|
|
| Albert Einstein College of Medicine – Bronx, New York, United States |
|
|
|
| University of Nottingham – Nottingham, England, United Kingdom |
|
|
|
| German Center for Lung Research – Giessen, Germany |
|
|
|
| University of Texas MD Anderson Cancer Center – Houston, Texas, United States |
|
|
|
|